Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$6.18 USD
+0.12 (1.98%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $6.18 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for Sight Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -55.55 | -86.24 | -62.96 | -34.69 | NA |
Depreciation/Amortization & Depletion | 1.23 | 1.37 | 1.33 | 1.13 | NA |
Net Change from Assets/Liabilities | -8.72 | -5.08 | -3.89 | 2.15 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 15.85 | 13.99 | 12.98 | -0.76 | NA |
Net Cash From Operating Activities | -47.18 | -75.97 | -52.54 | -32.17 | NA |
Property & Equipment | -0.79 | -0.97 | -0.81 | -0.95 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -0.79 | -0.97 | -0.81 | -0.95 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.33 | 1.25 | 257.04 | 53.11 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 20.48 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | -0.22 | 0.00 | -4.51 | -0.18 | NA |
Net Cash from Financing Activities | 1.10 | 1.25 | 252.53 | 73.40 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -46.87 | -75.69 | 199.18 | 40.27 | NA |
Cash at Beginning of Period | 185.00 | 260.69 | 61.51 | 21.24 | NA |
Cash at End of Period | 138.13 | 185.00 | 260.69 | 61.51 | NA |
Diluted Net EPS | -1.14 | -1.80 | -2.36 | NA | NA |
Fiscal Year End for Sight Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.60 | -16.27 | -55.55 | -44.86 | -31.82 |
Depreciation/Amortization & Depletion | 0.55 | 0.29 | 1.23 | 0.91 | 0.59 |
Net Change from Assets/Liabilities | -1.49 | 0.46 | -8.72 | -9.10 | -7.50 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.29 | 5.74 | 15.85 | 12.35 | 7.86 |
Net Cash From Operating Activities | -19.25 | -9.79 | -47.18 | -40.70 | -30.87 |
Property & Equipment | -0.20 | -0.12 | -0.79 | -0.53 | -0.22 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.20 | -0.12 | -0.79 | -0.53 | -0.22 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.61 | 0.15 | 1.33 | 0.95 | 0.83 |
Issuance (Repayment) of Debt | -0.85 | -0.85 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.26 | -0.24 | -0.22 | -0.22 | -0.22 |
Net Cash from Financing Activities | -0.50 | -0.94 | 1.10 | 0.73 | 0.61 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -19.95 | -10.85 | -46.87 | -40.50 | -30.49 |
Cash at Beginning of Period | 138.13 | 138.13 | 185.00 | 185.00 | 185.00 |
Cash at End of Period | 118.18 | 127.28 | 138.13 | 144.50 | 154.52 |
Diluted Net EPS | -0.25 | -0.33 | -0.22 | -0.27 | -0.30 |